These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 12789240)
1. Inhibition of the IL-4/IL-13 receptor system prevents allergic sensitization without affecting established allergy in a mouse model for allergic asthma. Hahn C; Teufel M; Herz U; Renz H; Erb KJ; Wohlleben G; Bröcker EB; Duschl A; Sebald W; Grunewald SM J Allergy Clin Immunol; 2003 Jun; 111(6):1361-9. PubMed ID: 12789240 [TBL] [Abstract][Full Text] [Related]
2. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-13: central mediator of allergic asthma. Wills-Karp M; Luyimbazi J; Xu X; Schofield B; Neben TY; Karp CL; Donaldson DD Science; 1998 Dec; 282(5397):2258-61. PubMed ID: 9856949 [TBL] [Abstract][Full Text] [Related]
4. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650 [TBL] [Abstract][Full Text] [Related]
5. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. Hopfenspirger MT; Agrawal DK J Immunol; 2002 Mar; 168(5):2516-22. PubMed ID: 11859146 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of IL-4/IL-13 does not enhance the efficacy of allergen immunotherapy in murine allergic airway inflammation. Gogishvili T; Hahn C; Meinhard J; Hohaus A; Erb K; Sebald W; Bröcker EB; Grunewald SM Int Arch Allergy Immunol; 2007; 142(2):165-74. PubMed ID: 17077644 [TBL] [Abstract][Full Text] [Related]
8. Effects of taraxasterol on ovalbumin-induced allergic asthma in mice. Liu J; Xiong H; Cheng Y; Cui C; Zhang X; Xu L; Zhang X J Ethnopharmacol; 2013 Jul; 148(3):787-93. PubMed ID: 23727181 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma. Wang Y; McCusker CT Clin Exp Allergy; 2005 Aug; 35(8):1104-11. PubMed ID: 16120094 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumin-induced allergic asthma in mice. Yin H; Li XY; Liu T; Yuan BH; Zhang BB; Hu SL; Gu HB; Jin XB; Zhu JY Clin Exp Immunol; 2012 Oct; 170(1):1-9. PubMed ID: 22943195 [TBL] [Abstract][Full Text] [Related]
11. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. Wild JS; Sigounas A; Sur N; Siddiqui MS; Alam R; Kurimoto M; Sur S J Immunol; 2000 Mar; 164(5):2701-10. PubMed ID: 10679111 [TBL] [Abstract][Full Text] [Related]
12. Requirement for IL-13 independently of IL-4 in experimental asthma. Grünig G; Warnock M; Wakil AE; Venkayya R; Brombacher F; Rennick DM; Sheppard D; Mohrs M; Donaldson DD; Locksley RM; Corry DB Science; 1998 Dec; 282(5397):2261-3. PubMed ID: 9856950 [TBL] [Abstract][Full Text] [Related]
13. Petiveria alliacea Suppresses Airway Inflammation and Allergen-Specific Th2 Responses in Ovalbumin-Sensitized Murine Model of Asthma. Rosa MPG; Jose MMF Chin J Integr Med; 2018 Dec; 24(12):912-919. PubMed ID: 30341485 [TBL] [Abstract][Full Text] [Related]
16. TNF-α enhance Th2 and Th17 immune responses regulating by IL23 during sensitization in asthma model. Lee HS; Park HW; Song WJ; Jeon EY; Bang B; Shim EJ; Moon HG; Kim YK; Kang HR; Min KU; Cho SH Cytokine; 2016 Mar; 79():23-30. PubMed ID: 26717421 [TBL] [Abstract][Full Text] [Related]
17. Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Van Oosterhout AJ; Van Esch B; Hofman G; Hofstra CL; Van Ark I; Nijkamp FP; Kapsenberg ML; Savelkoul HF; Weller FR Am J Respir Cell Mol Biol; 1998 Oct; 19(4):622-8. PubMed ID: 9761759 [TBL] [Abstract][Full Text] [Related]
18. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. Tomkinson A; Duez C; Cieslewicz G; Pratt JC; Joetham A; Shanafelt MC; Gundel R; Gelfand EW J Immunol; 2001 May; 166(9):5792-800. PubMed ID: 11313423 [TBL] [Abstract][Full Text] [Related]
19. Upon prolonged allergen exposure IL-4 and IL-4Ralpha knockout mice produce specific IgE leading to anaphylaxis. Grunewald SM; Teufel M; Erb K; Nelde A; Mohrs M; Brombacher F; Bröcker EB; Sebald W; Duschl A Int Arch Allergy Immunol; 2001 Aug; 125(4):322-8. PubMed ID: 11574754 [TBL] [Abstract][Full Text] [Related]
20. Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma. Moerch U; Haahr Hansen M; Vest Hansen NJ; Rasmussen LK; Oleksiewicz MB; Frandsen TP; Haurum JS; Bregenholt S Int Arch Allergy Immunol; 2006; 140(3):261-9. PubMed ID: 16699287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]